Staphylococcus Aureus Exploits Epidermal Barrier Defects in Atopic Dermatitis to Trigger Cytokine Expression

Overview

Journal J Invest Dermatol

Publisher Elsevier

Specialty Dermatology

Date 2016 Jul 7

PMID 27381887

Citations 150

Authors

Teruaki Nakatsuji

Tiffany H Chen

Aimee M Two

Kimberly A Chun

Saisindhu Narala

Raif S Geha

Tissa R Hata

Richard L Gallo

Affiliations

Soon will be listed here.

Abstract

Patients with atopic dermatitis (AD) have an abnormal skin barrier and are frequently colonized by S. aureus. In this study we investigated if S. aureus penetrates the epidermal barrier of subjects with AD and sought to understand the mechanism and functional significance of this entry. S. aureus was observed to be more abundant in the dermis of lesional skin from AD patients. Bacterial entry past the epidermis was observed in cultured human skin equivalents and in mice but was found to be increased in the skin of cathelicidin knockout and ovalbumin-sensitized filaggrin mutant mice. S. aureus penetration through the epidermis was dependent on bacterial viability and protease activity, because killed bacteria and a protease-null mutant strain of S. aureus were unable to penetrate. Entry of S. aureus directly correlated with increased expression of IL-4, IL-13, IL-22, thymic stromal lymphopoietin, and other cytokines associated with AD and with decreased expression of cathelicidin. These data illustrate how abnormalities of the epidermal barrier in AD can alter the balance of S. aureus entry into the dermis and provide an explanation for how such dermal dysbiosis results in increased inflammatory cytokines and exacerbation of disease.

Citing Articles

Skin-Protective Performance of Alternative Stratum Corneum Formed by a Pseudo-Ceramide-Containing Steroid Lamellar Cream.

Yokota M, Matsumoto T, Kawamoto A, Dojo K, Toyama S, Moniaga C Exp Dermatol. 2025; 34(3):e70041.

PMID: 40066914 PMC: 11894917. DOI: 10.1111/exd.70041.

The gut-skin axis: a bi-directional, microbiota-driven relationship with therapeutic potential.

Jimenez-Sanchez M, Celiberto L, Yang H, Sham H, Vallance B Gut Microbes. 2025; 17(1):2473524.

PMID: 40050613 PMC: 11901370. DOI: 10.1080/19490976.2025.2473524.

Crosstalk Between the Skin Environment and Microbial Community in Immune-Related Skin Diseases.

Liu K, Deng S, Zhou Y, Xu B, Zhang Y, Li W Clin Rev Allergy Immunol. 2025; 68(1):16.

PMID: 39954089 DOI: 10.1007/s12016-025-09029-2.

Interleukin-4 and Atopic Dermatitis: Why Does it Matter? A Narrative Review.

Torres T, Mendes-Bastos P, Cruz M, Duarte B, Filipe P, Lopes M Dermatol Ther (Heidelb). 2025; 15(3):579-597.

PMID: 39930311 DOI: 10.1007/s13555-025-01352-y.

Skin microbiota: pathogenic roles and implications in atopic dermatitis.

Huang C, Zhuo F, Guo Y, Wang S, Zhang K, Li X Front Cell Infect Microbiol. 2025; 14:1518811.

PMID: 39877655 PMC: 11772334. DOI: 10.3389/fcimb.2024.1518811.

References

Foelster Holst R, Reitamo S, Yankova R, Worm M, Kadurina M, Thaci D . The novel protease inhibitor SRD441 ointment is not effective in the treatment of adult subjects with atopic dermatitis: results of a randomized, vehicle-controlled study. Allergy. 2010; 65(12):1594-9. DOI: 10.1111/j.1398-9995.2010.02417.x. View

Hata T, Kotol P, Boguniewicz M, Taylor P, Paik A, Jackson M . History of eczema herpeticum is associated with the inability to induce human β-defensin (HBD)-2, HBD-3 and cathelicidin in the skin of patients with atopic dermatitis. Br J Dermatol. 2010; 163(3):659-61. PMC: 2966528. DOI: 10.1111/j.1365-2133.2010.09892.x. View

Schauber J, Dorschner R, Yamasaki K, Brouha B, Gallo R . Control of the innate epithelial antimicrobial response is cell-type specific and dependent on relevant microenvironmental stimuli. Immunology. 2006; 118(4):509-19. PMC: 1782325. DOI: 10.1111/j.1365-2567.2006.02399.x. View

Hoff S, Oyoshi M, MacPherson A, Geha R . The microbiota is important for IL-17A expression and neutrophil infiltration in lesional skin of Flg(ft/ft) mice. Clin Immunol. 2014; 156(2):128-30. PMC: 5800788. DOI: 10.1016/j.clim.2014.12.001. View

Moniaga C, Kabashima K . Filaggrin in atopic dermatitis: flaky tail mice as a novel model for developing drug targets in atopic dermatitis. Inflamm Allergy Drug Targets. 2011; 10(6):477-85. DOI: 10.2174/187152811798104881. View

Kolar S, Ibarra J, Rivera F, Mootz J, Davenport J, Stevens S . Extracellular proteases are key mediators of Staphylococcus aureus virulence via the global modulation of virulence-determinant stability. Microbiologyopen. 2012; 2(1):18-34. PMC: 3584211. DOI: 10.1002/mbo3.55. View

Redpath M, Foster T, Bailey C . The role of the serine protease active site in the mode of action of epidermolytic toxin of Staphylococcus aureus. FEMS Microbiol Lett. 1991; 65(2):151-5. DOI: 10.1016/0378-1097(91)90295-l. View

Sandilands A, Sutherland C, Irvine A, McLean W . Filaggrin in the frontline: role in skin barrier function and disease. J Cell Sci. 2009; 122(Pt 9):1285-94. PMC: 2721001. DOI: 10.1242/jcs.033969. View

Ong P, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T . Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med. 2002; 347(15):1151-60. DOI: 10.1056/NEJMoa021481. View

10.

Wang Z, MacLeod D, Di Nardo A . Commensal bacteria lipoteichoic acid increases skin mast cell antimicrobial activity against vaccinia viruses. J Immunol. 2012; 189(4):1551-8. PMC: 3411879. DOI: 10.4049/jimmunol.1200471. View

11.

Liu P, Stenger S, Li H, Wenzel L, Tan B, Krutzik S . Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006; 311(5768):1770-3. DOI: 10.1126/science.1123933. View

12.

Fallon P, Sasaki T, Sandilands A, Campbell L, Saunders S, Mangan N . A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming. Nat Genet. 2009; 41(5):602-8. PMC: 2872154. DOI: 10.1038/ng.358. View

13.

Hirasawa Y, Takai T, Nakamura T, Mitsuishi K, Gunawan H, Suto H . Staphylococcus aureus extracellular protease causes epidermal barrier dysfunction. J Invest Dermatol. 2009; 130(2):614-7. DOI: 10.1038/jid.2009.257. View

14.

Mallbris L, Carlen L, Wei T, Heilborn J, Nilsson M, Granath F . Injury downregulates the expression of the human cathelicidin protein hCAP18/LL-37 in atopic dermatitis. Exp Dermatol. 2009; 19(5):442-9. DOI: 10.1111/j.1600-0625.2009.00918.x. View

15.

Scharschmidt T, Vasquez K, Truong H, Gearty S, Pauli M, Nosbaum A . A Wave of Regulatory T Cells into Neonatal Skin Mediates Tolerance to Commensal Microbes. Immunity. 2015; 43(5):1011-21. PMC: 4654993. DOI: 10.1016/j.immuni.2015.10.016. View

16.

Schauber J, Dorschner R, Coda A, Buchau A, Liu P, Kiken D . Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J Clin Invest. 2007; 117(3):803-11. PMC: 1784003. DOI: 10.1172/JCI30142. View

17.

Vu A, Baba T, Chen X, Le T, Kinoshita H, Xie Y . Staphylococcus aureus membrane and diacylated lipopeptide induce thymic stromal lymphopoietin in keratinocytes through the Toll-like receptor 2-Toll-like receptor 6 pathway. J Allergy Clin Immunol. 2010; 126(5):985-93, 993.e1-3. DOI: 10.1016/j.jaci.2010.09.002. View

18.

Wanke I, Steffen H, Christ C, Krismer B, Gotz F, Peschel A . Skin commensals amplify the innate immune response to pathogens by activation of distinct signaling pathways. J Invest Dermatol. 2010; 131(2):382-90. DOI: 10.1038/jid.2010.328. View

19.

Smith F, Irvine A, Terron-Kwiatkowski A, Sandilands A, Campbell L, Zhao Y . Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris. Nat Genet. 2006; 38(3):337-42. DOI: 10.1038/ng1743. View

20.

Kong H, Oh J, Deming C, Conlan S, Grice E, Beatson M . Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res. 2012; 22(5):850-9. PMC: 3337431. DOI: 10.1101/gr.131029.111. View